ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

During Shark Week, New Ad Campaign Urges Congress to “Stop the Feeding Frenzy” on 340B Drug Pricing Program

Council for Citizens Against Government Waste launches effort urging Congress to address 340B reform promptly and responsibly to ensure greater accountability in the program

Today, the Council for Citizens Against Government Waste (CCAGW) launched a national multi-media campaign calling on Congress to reform the 340B Drug Pricing Program. CCAGW is urging lawmakers to prioritize bringing greater transparency and accountability to the program, which special interests have exploited by pocketing drug discounts meant for vulnerable patients. The campaign focuses on widespread abuses in the program and outlines what Congress needs to do to ensure greater accountability and transparency, including strongly defining what constitutes a 340B patient.

“340B program costs have increased substantially over the past 10 years, and it’s time for Congress to adopt reforms that will finally serve the patients and communities that need it most,” said Tom Schatz, President, Council for Citizens Against Government Waste. “Since its inception in 1992, the 340B Drug Pricing Program’s mission has been to provide affordable medications to those most in need, but a lack of transparency and accountability has instead allowed special interests to circle like sharks in a feeding frenzy to line their own pockets.”

Click To View Ad

Click HERE for more information about the campaign and to view the ads. Click HERE for more information on how to enhance accountability and transparency in the 340B Drug Pricing Program.

Under 340B, which is the second-largest federal prescription drug program, safety-net hospitals and health care providers are expanding the scope of the program beyond what was originally intended by Congress and are doing so in a manner that does not benefit patients. Congress must act to reform the 340B Program to deliver savings to the patients and communities it was designed to serve. CCAGW remains committed to prioritizing reforms that improve patient access while ensuring proper accountability and transparency of this critical program.

CCAGW is a nonprofit organization that engages in lobbying and grassroots activities to eliminate waste, fraud, abuse, and mismanagement in government.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.